Atlas Trials

Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam

Clinical trial NCT04182191 · COMPLETED

Trial details

NCT number
NCT04182191
Sponsor
University of Sao Paulo
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Molar, ThirdPain
Start date
2018-03-01
Primary completion
2019-07-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.